NCT01245621 Study of Palliative Care Intervention for Advanced Cancer Patients and Their Caregivers -Educate Nurture Advise Before Life Ends (ENABLE III) Status COMPLETED Phase NA
NCT01241929 Using Videos in Advance Care Planning for Patients With Advanced Cancer Status COMPLETED Phase NA
NCT01212107 A Phase 1 Study of LY2874455 in Participants With Advanced Cancer Status COMPLETED Phase PHASE1
NCT01209832 A Tasisulam and Midazolam Drug Interaction Study in Cancer Patients Status TERMINATED Phase PHASE1
NCT01197170 Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome Resistance Status COMPLETED Phase PHASE1
NCT01187199 Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT01185548 A Drug Interaction Study of Tasisulam in Patients With Advanced Cancer or Lymphoma Status TERMINATED Phase PHASE1
NCT01143779 FLT-PET as an Imaging Biomarker With Temsirolimus, Topotecan, and Bortezomib Status COMPLETED Phase PHASE1
NCT01113476 Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced Malignancies Status COMPLETED Phase PHASE1
NCT01087554 Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT01072266 A Dose-escalation Study in Subjects With Advanced Malignancies Status COMPLETED Phase PHASE1
NCT01054313 Docetaxel and Sirolimus in Patients With Advanced Malignancies Status COMPLETED Phase PHASE1
NCT01048008 Study of 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced Cancer Status COMPLETED Phase PHASE1